Insider trades
When an officer, director or 10% holder of a company buys or sells its shares, they file a Form 4 with the SEC within two business days.
The question it answers: Are the people who run this company buying or selling its stock?
OQRO reads the documents that US law obliges companies, insiders, members of Congress, funds and agencies to publish, and puts them on one page per company, in plain words, each linked to its source. It does not forecast, rate or recommend anything. Here is what each kind of record is and the one question it answers.
One minute in OQRO: a company page, its insider and Congress trades, and the official filing behind each one.
When an officer, director or 10% holder of a company buys or sells its shares, they file a Form 4 with the SEC within two business days.
The question it answers: Are the people who run this company buying or selling its stock?
Members of Congress must disclose their stock trades within 45 days; OQRO reads the House and Senate reports and shows each trade with its value range.
The question it answers: Which members of Congress traded this stock, and when?
Latest politician trades · How to read a Congress trade report
Every quarter, funds managing over $100 million list their US stock holdings on Form 13F; OQRO shows what each fund opened, added, trimmed or sold out.
The question it answers: Which large funds own this stock, and are they adding or cutting?
Every federal contract award is published on USAspending; OQRO links awards to listed companies with the agency, the amount obligated and the ceiling.
The question it answers: How much does the US government pay this company?
When a listed company agrees to buy or be bought, it files a Form 8-K; OQRO reads the filing and shows who buys whom and the terms the company disclosed.
The question it answers: Is this company being acquired, and at what price?
Mergers and acquisitions · How to read a merger announcement
Beyond SEC filings: FDA approvals and recalls, vehicle recalls, layoff notices, securities lawsuits, clinical trials, CFPB complaints, CEO pay and corporate PACs, each from its official source.
The question it answers: What do regulators, courts and agencies have on file about this company?
It never says why someone traded, never predicts a price, never rates a company and never calls a trade a signal. A filing says what was done and when; OQRO shows that and links the document. The methodology page says how each source is read and what it leaves out.